RCWM
CRMD icon

Royal Capital Wealth Management’s CorMedix CRMD Stock Holding History

Royal Capital Wealth Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Hold
28,500
– – 0.13% 91
2026
Q1 		$194K Buy
+28,500
New +$211K 0.12% 94

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Royal Capital Wealth Management's CRMD Position: Q2 2026 in Review

Royal Capital Wealth Management held its CorMedix (CRMD) position steady in Q2 2026 at 28,500 shares worth $224K. The position accounts for 0.13% of the portfolio, ranked #91.

Royal Capital Wealth Management first reported a position in CRMD in Q1 2026 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Royal Capital Wealth Management held 28,500 shares of CorMedix worth $224K as of Q2 2026.
  • Royal Capital Wealth Management left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up 0.13% of Royal Capital Wealth Management's portfolio in Q2 2026, its #91 holding.
  • Royal Capital Wealth Management first reported a position in CorMedix in Q1 2026 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Royal Capital Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.